Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Finasteride effectively treats BPH but requires continuous use to maintain benefits.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Serum triglyceride levels are not linked to prostate cancer risk.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The normal human prostate does not significantly affect blood DHT levels.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Dutasteride may help shrink prostate cancer tumors.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Vertex pattern hair loss linked to higher prostate cancer risk.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

The dog's fertility was restored with antibiotics and finasteride treatment.